Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Servier Venturesservier.com · Low evidenceServier is a global pharmaceutical company focused on therapeutic areas including hypertension, oncology, and rare diseases. The company emphasizes patient partnership and innovation, as seen in its acquisition of Day One Biopharmaceuticals to strengthen its rare cancer portfolio.
Parse Score